TY  - JOUR 
AU  - Gruppo, Ralph
AU  - López Fernández, María Fernanda
AU  - Wynn, Tung T
AU  - Engl, Werner
AU  - Sharkhawy, Marlies
AU  - Tangada, Srilatha
PY  - 2019
SN  - 1351-8216
UR  - http://hdl.handle.net/20.500.11940/15912
AB  - INTRODUCTION: Rurioctocog alfa pegol (BAX 855, TAK-660) is a PEGylated, full-length, recombinant factor VIII (rFVIII) with extended half-life developed from unmodified rFVIII (antihaemophilic factor [recombinant]). AIM: To determine the perioperative...
LA  - eng
KW  - Hemophilia A
KW  - Adult
KW  - Middle Aged
KW  - Humans
KW  - Treatment Outcome
KW  - Factor VIII
KW  - Young Adult
KW  - Adolescent
KW  - Hemostasis
TI  - Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial
DO  - 10.1111/hae.13807
T2  - HAEMOPHILIA
KW  - CHUAC
VL  - 25
ER  -